The coronavirus disease 2019 (COVID-19) pandemic has brought significant challenges to many aspects of healthcare delivery since the first reported case in early December 2019. Once in the body, SARS-CoV-2 can spread to other digestive organs, such as the liver, because of the presence of ACE2 receptors. Colorectal cancer (CRC) remains the second-leading cause of death in the United States (US). Therefore, individuals are routinely screened using either endoscopic methods (i.e., flexible sigmoidoscopy and colonoscopy) or stool-based tests, as per the published guidelines. At the beginning of the COVID-19 pandemic, the Centers for Medicare and Medicaid Services (CMS) recommended that all non-urgent surgical and medical procedures, including screening colonoscopies, be delayed until the pandemic stabilization. This article aims to review the impact of COVID-19 on CRC screening.
【저자키워드】 COVID-19, SARS-CoV-2, colorectal cancer screening, 【초록키워드】 coronavirus disease, Coronavirus disease 2019, pandemic, COVID-19 pandemic, Cancer, surgical, Colorectal cancer, Colorectal, healthcare, Colonoscopy, death, ACE2 receptors, United States, cause of death, liver, medical procedures, Medicaid, flexible sigmoidoscopy, individual, center, organs, service, Medicare, flexible, spread to, reported, the United State, screened, digestive, 【제목키워드】 Colorectal, Impact, direction, Future, insight, current,